Latest GMI Study Abstracts

Latest GMI Study Abstracts

Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats.

Article Published Date : Feb 03, 2025
Study Type : Animal Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319)
Diseases : Inflammation : CK(16094) : AC(5496)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858)

The beneficial effects of curcumin on aging and age-related diseases.

Article Published Date : Dec 31, 2024
Study Type : Review
Additional Links
Substances : Curcumin : CK(7239) : AC(3319)
Diseases : Aging : CK(6221) : AC(1510)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Antioxidants : CK(34551) : AC(14499), Cyclooxygenase 2 Inhibitors : CK(2264) : AC(1327), NF-kappaB Inhibitor : CK(5952) : AC(3464)

Pre-clinical and clinical efficacy of curcumin as an anti-inflammatory agent for periodontitis.

Article Published Date : Dec 31, 2023
Study Type : Review
Additional Links
Substances : Curcumin : CK(7239) : AC(3319)
Diseases : Periodontitis : CK(1328) : AC(311)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858), Interleukin-10 upregulation : CK(1296) : AC(436), Interleukin-4 upregulation : CK(182) : AC(70), Interleukin-6 Downregulation : CK(9337) : AC(3613), Tumor Necrosis Factor (TNF) Alpha Inhibitor : CK(11697) : AC(4806)

Curcumin-loaded zein and shellac composite nanoparticles for ulcerative colitis treatment.

Article Published Date : Mar 31, 2025
Study Type : Animal Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319)
Diseases : Ulcerative Colitis : CK(1411) : AC(447)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499)

Hyaluronic acid-curcumin nanoparticles for preventing the progression of experimental autoimmune uveitis.

Article Published Date : Feb 06, 2025
Study Type : Animal Study, In Vitro Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319), Hyaluronic Acid : CK(249) : AC(39)
Diseases : Oxidative Stress : CK(14758) : AC(5716), Uveitis : CK(156) : AC(40)
Pharmacological Actions : Antioxidants : CK(34551) : AC(14499), Heme oxygenase-1 up-regulation : CK(1336) : AC(776), Nrf2 activation : CK(3156) : AC(1794)

Probing the role of coniferin and tetrahydrocurcumin from Traditional Chinese medicine against PSAT1 in early-stage ovarian cancer.

Article Published Date : Dec 31, 2024
Study Type : In Vitro Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319), Tetrahydrocurcumin : CK(173) : AC(99)
Diseases : Ovarian Cancer : CK(1029) : AC(509)
Pharmacological Actions : Chemotherapeutic : CK(4390) : AC(1635)

Tetrahydrocurcumin exhibits neuroprotective effects by inhibiting neuron ferroptosis.

Article Published Date : Jan 31, 2025
Study Type : In Vitro Study
Additional Links
Substances : Tetrahydrocurcumin : CK(173) : AC(99)
Diseases : Brain Injury: Traumatic : CK(383) : AC(131)
Pharmacological Actions : Neuroprotective Agents : CK(20061) : AC(7949)

Curcumin inhibits growth and triggers apoptosis in human castration-resistant prostate cancer cells.

Article Published Date : Jan 31, 2025
Study Type : In Vitro Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319)
Diseases : Prostate Cancer : CK(2805) : AC(1046)
Pharmacological Actions : Antiproliferative : CK(10001) : AC(7491), Apoptotic : CK(9585) : AC(7379)

Curcumin modulates PTPRZ1 activity and RNA m6A modifications in neuroinflammation-associated microglial response.

Article Published Date : Feb 07, 2025
Study Type : Animal Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319)
Diseases : Brain Inflammation : CK(1784) : AC(928)
Pharmacological Actions : Anti-Inflammatory Agents : CK(39737) : AC(15858)

Hepatic fibroblast growth factor 21 is required for curcumin or resveratrol in exerting their metabolic beneficial effect in male mice.

Article Published Date : Feb 09, 2025
Study Type : Animal Study
Additional Links
Substances : Curcumin : CK(7239) : AC(3319), Resveratrol : CK(3228) : AC(1513)
Diseases : Metabolic Diseases : CK(1273) : AC(272), Obesity : CK(11004) : AC(2672)
Pharmacological Actions : Gastrointestinal Agents : CK(7657) : AC(2274), Hepatoprotective : CK(8989) : AC(3831)

Connect with GreenMedInfo